How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

6,247 results for

Depression Screening Tools

by
...
Latest & greatest
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

81. Application of Assessment Tools to Examine Mental Health in Workplaces: Job Stress and Depression Full Text available with Trip Pro

and depression, in workplaces. These tools can be used by clinicians or professionals involved in the mental health, occupational safety, or health service fields for running diagnostics or screening tests. (...) Application of Assessment Tools to Examine Mental Health in Workplaces: Job Stress and Depression Despite the fact that the lifetime and yearly prevalence rates of mental illness continue rising, such diseases have only been acknowledged as involved in workplace health issue since the 2000s. Additionally, while the number of recognized cases of mental illnesses is rather low compared to their prevalence, they have a high likelihood of causing significant problems, including fatalities. Many

2018 Psychiatry investigation

82. Screening, referral and treatment for depression in patients with coronary heart disease Full Text available with Trip Pro

on a yearly basis, as for any other major risk factor for CHD. A simple tool for initial screening, such as the Patient Health Questionnaire-2 (PHQ-2) or the short-form Cardiac Depression Scale (CDS), can be incorporated into usual clinical practice with minimum interference, and may increase uptake of screening. Patients with positive screening results may need further evaluation. Appropriate treatment should be commenced, and the patient monitored. If screening is followed by comprehensive care (...) higher prevalence of depression in patients with CHD. It is important to recognise depression in patients with CHD in order to provide the best possible care. Asymptomatic patients with significant cardiovascular risk factors (eg, those with diabetes) may also be considered for screening, as they have a high risk of depression. Many self-reported screening tools exist with the aim of detecting possible depression. These include the Patient Health Questionnaire (PHQ-2, PHQ-9), the Cardiac Depression

2013 Clinical Practice Guidelines Portal

83. Postnatal depression

. Definition Postnatal depression refers to the development of a depressive illness following childbirth and may form part of a bipolar or, more usually, a unipolar illness. Musters C, McDonald E, Jones I. Management of postnatal depression. BMJ. 2008 Aug 8;337:a736. http://www.ncbi.nlm.nih.gov/pubmed/18689433?tool=bestpractice.com Postnatal depression is not recognised by current classification systems as a condition in its own right, but the onset of a depressive episode within 4 weeks of childbirth can (...) : results of a family study. Am J Psychiatry. 2006 Sep;163(9):1549-53. http://ajp.psychiatryonline.org/doi/full/10.1176/ajp.2006.163.9.1549 http://www.ncbi.nlm.nih.gov/pubmed/16946179?tool=bestpractice.com Hence, in common usage, depressive episodes occurring within 6-12 months of delivery may be considered to be postnatal depression. History and exam presence of risk factors depressed mood anhedonia decreased energy or increased fatigability suicidal ideation loss of confidence or self-esteem

2019 BMJ Best Practice

84. Screening for depression in cancer patients receiving radiotherapy: Feasibility and identification of effective tools in the NRG Oncology RTOG 0841 trial. Full Text available with Trip Pro

Screening for depression in cancer patients receiving radiotherapy: Feasibility and identification of effective tools in the NRG Oncology RTOG 0841 trial. Brief tools are needed to screen oncology outpatients for depressive symptoms.Patients starting radiotherapy for the first diagnosis of any tumor completed distress screening tools, including the 9-item Patient Health Questionnaire (PHQ-9), the 2-item Patient Health Questionnaire (PHQ-2), the National Comprehensive Cancer Network Distress (...) , and the eligible patients had breast (45%), gastrointestinal (11%), lung (10%), gynecologic (6%), or other cancers (27%). Seventy-five (16.5%) exceeded screening cutoffs for depressive symptoms. Forty-two of these patients completed the SCID. Another 37 patients whose screening was negative completed the SCID. Among the 79 patients completing the SCID, 8 (10.1%) met the criteria for major depression, 2 (2.5%) met the criteria for dysthymia, and 6 (7.6%) met the criteria for an adjustment disorder. The PHQ-2

2016 Cancer

85. Development and validation of the NDDI-E-Y: a screening tool for depressive symptoms in pediatric epilepsy. Full Text available with Trip Pro

Development and validation of the NDDI-E-Y: a screening tool for depressive symptoms in pediatric epilepsy. To validate the revised 12-item revised Neurological Disorders Depression Inventory-Epilepsy for Youth (NDDI-E-Y), a self-report screening tool for depressive symptoms tailored to youth ages 12-17 with epilepsy.Youth at two sites completed the NDDI-E-Y during a routine epilepsy visit. Youth at one site also completed the Children's Depression Inventory-2 (CDI-2). Seizure and demographic (...) -Y were high.Reliability and construct validity were established for the revised 12-item NDDI-E-Y. The NDDI-E-Y is a brief, free measure of depressive symptoms that can be administered during a routine epilepsy visit.Wiley Periodicals, Inc. © 2016 International League Against Epilepsy.

2016 Epilepsia

86. Validation of screening tools for depression and anxiety disorders in a primary care population with high HIV prevalence in Zimbabwe. Full Text available with Trip Pro

Validation of screening tools for depression and anxiety disorders in a primary care population with high HIV prevalence in Zimbabwe. In low income countries in Sub-Saharan Africa there are few validated tools to screen for common disabling mental disorders such as depression and general anxiety disorder (GAD).We validated three screening tools: the Shona Symptom Questionnaire for common mental disorders (SSQ-14), the Patient Health Questionnaire for depression (PHQ-9), and the Generalized (...) -81%) respectively. Internal reliability was high (Cronbach α=0.74). The optimal cutoff for PHQ-9 was ≥11, which provided a sensitivity of 85% (95%CI:78-90%) and specificity of 69% (95%CI:59-77%) against a SCID diagnosis of depression (Cronbach α=0.86). The GAD-7 (optimal cutoff ≥10) had sensitivity and specificity of 89% (95%CI:81-94%) and 73% (95%CI:65-80%) respectively against a SCID diagnosis of GAD (Cronbach α=0.87).Screening tools for depression and GAD had good performance characteristics

2016 Journal of Affective Disorders

87. Two-question screening for depression in older adults

the search. However, we are not provided with the full search terms and, rather than a single search looking for studies evaluating screening tools of depression in older people, the authors used a two stage approach of generating a list of screening tools and then seeking studies for each instrument, using keywords of ‘depression’ and ‘elderly’. They also did not contact experts in the field, ask for unpublished data or include non-English language articles. These deviations from best practice may have (...) Two-question screening for depression in older adults Two-question screening for depression in older adults Search National Elf Service Search National Elf Service » » » » Two-question screening for depression in older adults Mar 31 2017 Posted by This is the second in a series of Mental Elf blogs produced in partnership with the British Journal of Psychiatry. Each month we select a new paper from the BJPsych to be blogged by a young psychiatrist with research experience. We’re really excited

2017 The Mental Elf

88. The impact of care farms on quality of life, depression and anxiety among different population groups: A systematic review Full Text available with Trip Pro

The impact of care farms on quality of life, depression and anxiety among different population groups: A systematic review The impact of care farms on quality of life, depression and anxiety among different population groups: A systematic review - Murray - 2019 - Campbell Systematic Reviews - Wiley Online Library By continuing to browse this site, you agree to its use of cookies as described in our . Search within Search term Search term SYSTEMATIC REVIEW Open Access The impact of care farms (...) on quality of life, depression and anxiety among different population groups: A systematic review Academic Unit of Public Health, Leeds Institute of Health Sciences, University of Leeds, Leeds, UK Academic Unit of Public Health, Leeds Institute of Health Sciences, University of Leeds, Leeds, UK Plant Research International, Wageningen University, Wageningen, The Netherlands Care Farming UK, Bedminster, UK Academic Unit of Public Health, Leeds Institute of Health Sciences, University of Leeds, Leeds, UK

2019 Campbell Collaboration

89. Systematic Review - Relationship of Deployment-related Mild Traumatic Brain Injury to Posttraumatic Stress Disorder, Depressive Disorders, Substance Use Disorders, Suicidal Ideation, and Anxiety Disorders

245 duplicate citations, we screened 1,215 abstracts. Seven hundred forty records were excluded, leaving 475 citations to be reviewed at the full text level. We excluded 434 articles for one or more of the reasons listed above; 41 studies were included in the review. Key Question 1 We identified 11 studies of national samples and 22 studies of geographically diverse samples reporting prevalence and/or severity of PTSD, depressive disorders, substance use disorders, suicidal ideation or attempts (...) , or a positive screen) were generally more prevalent in Veterans with a history of TBI (mTBI or TBI unspecified) vs no-TBI and service members with a history of mTBI vs no-TBI. In studies reporting a higher prevalence in the groups with a history of TBI vs no TBI, differences ranged from 8% to 28%. One study reported a higher prevalence of major depressive disorder in service members with a history of mTBI with loss of consciousness compared to no TBI but similar prevalence for mTBI with altered state

2019 Veterans Affairs Evidence-based Synthesis Program Reports

90. Treatment of Depression in Children and Adolescents

not otherwise specified. We searched five databases and other sources for evidence available from inception to May 29, 2019, dually screened the results, and analyzed eligible studies. Results. We included in our analyses data from 60 studies (94 articles) that met our review eligibility criteria. For adolescents (study participants’ ages range from 12 to 18 years) with MDD, cognitive behavioral therapy (CBT), fluoxetine, escitalopram, and combined fluoxetine and CBT may improve depressive symptoms (1 (...) Treatment of Depression in Children and Adolescents Treatment of Depression in Children and Adolescents: A Systematic Review Comparative Effectiveness Review Number 224 R Comparative Effectiveness Review Number 224 Treatment of Depression in Children and Adolescents: A Systematic Review Prepared for: Agency for Healthcare Research and Quality U.S. Department of Health and Human Services 5600 Fishers Lane Rockville, MD 20857 www.ahrq.gov Contract No. 290-2015-00011-I Prepared by: RTI

2020 Effective Health Care Program (AHRQ)

91. Standardized Library of Depression Outcome Measures

of followup. Additional measurements outside of the windows listed above are recommended as supplemental measures. Events of Interest Adverse Events Depression treatment-related adverse events. Use of a brief, publicly available, validated measurement tool to capture adverse events is recommended. Reported in 12-month intervals. A-4 OMF CATEGORY OUTCOME MEASURE DEFINITION Events of Interest Suicide Ideation & Behavior Selection of ‘several days’, ‘more than half the days’ or ‘nearly every day’ option (...) Standardized Library of Depression Outcome Measures Research White Paper Standardized Library of Depression Outcome MeasuresResearch White Paper Standardized Library of Depression Outcome Measures Prepared for: Agency for Healthcare Research and Quality U.S. Department of Health and Human Services 5600 Fishers Lane Rockville, MD 20857 www.ahrq.gov Contract No. 290-2014-00004-C Prepared by: L&M Policy Research, LLC Washington, DC 20009 With partners: OM1, AcademyHealth Investigators: Richard E

2020 Effective Health Care Program (AHRQ)

92. End-stage Renal Disease and Depression: A Systematic Review

disorder (MDD) at three to more than six times that of the general US population, and Veterans experience MDD at more than twice the rate of the general US population. The Centers for Medicare and Medicaid Services’ (CMS) requires routine depression screening for patients with ESRD. However, due to the lack of system-wide screening tool requirements, there is wide variation in the tools used to initially screen for depression. In addition, there is no established standard guiding the treatment (...) of patients with ESRD and comorbid MDD. Given the wide variation in depression screening and treatment options for Veterans with ESRD, an understanding of the validity of screening tools used in both VA and community settings – and the subsequent depression treatment-related outcomes for Veterans in all US healthcare settings – is vital. Comorbid depression in patients with ESRD is associated with treatment noncompliance, poorer quality of life, worse sleep, increased emergency department (ED) visits

2020 Veterans Affairs - R&D

93. Management of screen-detected lung nodules: a Canadian Partnership against Cancer guidance document Full Text available with Trip Pro

identified numerous challenges such as the use of wrong scanning protocols, variable LDCT reporting, incorrect nodule diameter measurement resulting in false-positives and mixed tracking tools for follow-up. The study points to the importance of a standardized screening protocol. Management of screen-detected lung nodules: A Canadian partnership against cancer guidance document All authors , , , , , , , , , , , , , , , , , , , , , , , , , & Published online: 14 October 2020 Figure 1. Overview of the lung (...) Management of screen-detected lung nodules: a Canadian Partnership against Cancer guidance document Full article: Management of screen-detected lung nodules: A Canadian partnership against cancer guidance document | Search in: Journal Revue canadienne des soins respiratoires et critiques et de la médecine du sommeil 318 Views 0 CrossRef citations to date Altmetric Guidelines/Position Papers Management of screen-detected lung nodules: A Canadian partnership against cancer guidance document

2020 CPG Infobase

94. Postnatal depression

. Definition Postnatal depression refers to the development of a depressive illness following childbirth and may form part of a bipolar or, more usually, a unipolar illness. Musters C, McDonald E, Jones I. Management of postnatal depression. BMJ. 2008 Aug 8;337:a736. http://www.ncbi.nlm.nih.gov/pubmed/18689433?tool=bestpractice.com Postnatal depression is not recognised by current classification systems as a condition in its own right, but the onset of a depressive episode within 4 weeks of childbirth can (...) : results of a family study. Am J Psychiatry. 2006 Sep;163(9):1549-53. http://ajp.psychiatryonline.org/doi/full/10.1176/ajp.2006.163.9.1549 http://www.ncbi.nlm.nih.gov/pubmed/16946179?tool=bestpractice.com Hence, in common usage, depressive episodes occurring within 6-12 months of delivery may be considered to be postnatal depression. History and exam presence of risk factors depressed mood anhedonia decreased energy or increased fatigability suicidal ideation loss of confidence or self-esteem

2018 BMJ Best Practice

95. Psychometric properties and factor structure of the General Health Questionnaire as a screening tool for anxiety and depressive symptoms in a multi-national study of young adults. Full Text available with Trip Pro

Psychometric properties and factor structure of the General Health Questionnaire as a screening tool for anxiety and depressive symptoms in a multi-national study of young adults. Globally, common psychiatric disorders such as depression and anxiety are among the leading causes of morbidity and mortality. The 12-item General Health Questionnaire (GHQ-12) is a widely used questionnaire for screening or detecting common psychiatric disorders. The purpose of this study was to examine (...) mean square error of approximation (RMSEA), and standardized root mean squared residual, were all in acceptable ranges across study sites. The CFI values for Chile, Ethiopia, Peru and Thailand were 0.964, 0.951, 0.949, and 0.931, respectively. The corresponding RMSEA values were 0.051, 0.050, 0.059, and 0.059.Overall, we documented cross-cultural comparability of the GHQ-12 for assessing common psychiatric disorders such as symptoms of depressive and anxiety disorders among young adults. Although

2015 Journal of Affective Disorders

96. Screening for cognitive dysfunction in unipolar depression: Validation and evaluation of objective and subjective tools. (Abstract)

Screening for cognitive dysfunction in unipolar depression: Validation and evaluation of objective and subjective tools. Persistent cognitive dysfunction in unipolar depression (UD) contributes to socio-occupational impairment, but there are no feasible methods to screen for and monitor cognitive dysfunction in this patient group. The present study investigated the validity of two new instruments to screen for cognitive dysfunction in UD, and their associations with socio-occupational (...) capacity.Participants (n=53) with UD in partial or full remission and healthy control persons (n=103) were assessed with two new screening instruments, the Danish translations of the Screen for Cognitive Impairment in Psychiatry (SCIP-D) and Cognitive Complaints in Bipolar Disorder Rating Assessment (COBRA) and with established neuropsychological and self-assessment measures. Depression symptoms and socio-occupational function were rated with the Hamilton Depression Rating Scale and Functional Assessment Short Test

2015 Journal of Affective Disorders

97. What is the best tool for screening antenatal depression? (Abstract)

What is the best tool for screening antenatal depression? Antenatal depression (AD) can have devastating consequences. No existing scales are specifically designed to measure it. Common practice is to adapt scales originally developed for other circumstances. We designed this study to validate and determine the psychometric values for AD screening in Brazil.We collected clinical and socio-demographic data in the second gestational trimester. The following instruments were also administered (...) during that period: MINI-PLUS, EPDS, BDI and HAM-D.At the time of assessment, 17.34% of the patients were depressed, and 31.98% met the diagnostic criteria for lifetime major depression. All instruments showed an area under the curve in a receiver operating characteristic analysis greater than 0.85, with the BDI achieving a 0.90 and being the best-performing screening instrument. A score ≥11 on the EPDS (81.58% sensitivity, 73.33% specificity), ≥15 on the BDI (82.00% sensitivity, 84.26% specificity

2015 Journal of Affective Disorders

98. A computerized version of the Patient Health Questionnaire-4 as an ultra-brief screening tool to detect emotional disorders in primary care. (Abstract)

A computerized version of the Patient Health Questionnaire-4 as an ultra-brief screening tool to detect emotional disorders in primary care. The Patient Health Questionnaire-4 (PHQ-4) is an ultra-brief self-report consisting of a 2-item depression scale (PHQ-2) and a 2-item anxiety scale (GAD-2). The aim of the present study is to determine the psychometric properties of a computerized version of the PHQ-4 used to detect emotional disorders (anxiety and depression) in the primary care setting.A (...) disorders.This is the first study to provide evidence for the reliability and validity of a computerized version of the PHQ-4. This computerized tool can be used to detect depression and anxiety in a primary care setting.Copyright © 2018 Elsevier B.V. All rights reserved.

2018 Journal of Affective Disorders

99. Development and validation of a mental health screening tool for asylum-seekers and refugees: the STAR-MH. Full Text available with Trip Pro

Development and validation of a mental health screening tool for asylum-seekers and refugees: the STAR-MH. There is no screening tool for major depressive disorder (MDD) or post-traumatic stress disorder (PTSD) in asylum-seekers or refugees (ASR) that can be readily administered by non-mental health workers. Hence, we aimed to develop a brief, sensitive and rapidly administrable tool for non-mental health workers to screen for MDD and PTSD in ASR.The screening tool was developed from an extant (...) dataset (n = 121) of multiply screened ASR and tested prospectively (N = 192) against the M.I.N.I. (Mini International Neuropsychiatric Interview) structured psychiatric interview. Rasch, Differential Item Functioning and ROC analyses evaluated the psychometric properties and tool utility.A 9-item tool with a median administration time of six minutes was generated, comprising two 'immediate screen-in' items, and a 7-item scale. The prevalence of PTSD &/or MDD using the M.I.N.I. was 32%, whilst 99

2018 BMC Psychiatry

100. Predictive values of two frailty screening tools in older patients with solid cancer: a comparison of SAOP2 and G8 Full Text available with Trip Pro

Predictive values of two frailty screening tools in older patients with solid cancer: a comparison of SAOP2 and G8 Comprehensive Geriatric Assessment (CGA), the gold standard for detecting frailty in elderly cancer patients, is time-consuming and hard to apply in routine clinical practice. Here we compared the performance of two screening tools for frailty, G8 and SAOP2 for their accuracy in identifying vulnerable patients.We tested G8 and SAOP2 in 282 patients aged 65 or older with a diagnosis (...) of solid cancer and candidate to undergo surgical, medical and/or radiotherapy treatment. CGA, including functional and cognitive status, depression, nutrition, comorbidity, social status and quality of life was used as reference. ROC curves were used to compare two screening tools.Mean patient age was 79 years and 54% were female. Colorectal and breast cancer were the most common types cancer (49% and 24%). Impaired CGA, G8, and SAOP2 were found in 62%, 89%, and 94% of the patients, respectively

2018 Oncotarget

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>